Heather A. Hirsch, Ph.D.

2003 Michigan State University, East Lansing, MI 
Molecular Biology
"Heather Hirsch"


Sign in to add mentor
R. William Henry grad student 2003 Michigan State
 (Regulation of U6 small nuclear RNA transcription by the retinoblastoma tumor suppressor protein.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hirsch HA, Reeves J, Zi T, et al. (2017) Biomarker-driven indication selection in JTX-2011 ICONIC clinical trial. Journal of Clinical Oncology. 35: 11602-11602
Haines BB, Javaid S, Cui L, et al. (2017) Abstract 4714: Blockade of LAG-3 amplifies immune activation signatures and augments curative antitumor responses to anti-PD-1 therapy in immune competent mouse models of cancer Cancer Research. 77: 4714-4714
Hirsch H, Mangadu R, Cai M, et al. (2016) Abstract B114: Evaluation of the antitumor activity and molecular characterization of mouse syngeneic tumor models in response to anti-PD-1 treatment as a single agent and in combination with approved agents Cancer Immunology Research. 4
Deshpande A, Growdon WB, Hirsch H, et al. (2016) Abstract A052: Characterization of immune regulatory molecules B7-H4, PD-L1, and ICOS in micro-satellite stable (MSS) and micro-satellite instable (MSI) endometrial tumors Cancer Immunology Research. 4
Pinheiro EM, Hinton M, Mangadu R, et al. (2016) Abstract 543: Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab Cancer Research. 76: 543-543
Pinheiro EM, Mangadu R, Phan UT, et al. (2015) Abstract 269: Evaluation of the antitumor activity of anti-PD-1 immunotherapy as a single agent and in combination with approved agents in preclinical tumor models Cancer Research. 75: 269-269
Hirsch HA, Pinheiro EM, Cai M, et al. (2015) Abstract 1328: Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy Cancer Research. 75: 1328-1328
Ayers MD, Nebozhyn M, Hirsch HA, et al. (2015) Abstract 1307: Assessment of gene expression in peripheral blood from patients with advanced melanoma using RNA-seq before and after treatment with anti-PD-1 therapy with pembrolizumab (MK-3475) Cancer Research. 75: 1307-1307
Muvaffak A, Pan Q, Yan H, et al. (2014) Evaluating TBK1 as a therapeutic target in cancers with activated IRF3. Molecular Cancer Research : McR. 12: 1055-66
Hatch H, Booher R, Perera S, et al. (2013) Abstract 698: MCL1 dependent cells are sensitive to the CDK inhibitor Dinaciclib. Cancer Research. 73: 698-698
See more...